20-63346437-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The NM_000744.7(CHRNA4):c.*301C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000869 in 575,692 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.00072 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00092 ( 0 hom. )
Consequence
CHRNA4
NM_000744.7 3_prime_UTR
NM_000744.7 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.638
Genes affected
CHRNA4 (HGNC:1958): (cholinergic receptor nicotinic alpha 4 subunit) This gene encodes a nicotinic acetylcholine receptor, which belongs to a superfamily of ligand-gated ion channels that play a role in fast signal transmission at synapses. These pentameric receptors can bind acetylcholine, which causes an extensive change in conformation that leads to the opening of an ion-conducting channel across the plasma membrane. This protein is an integral membrane receptor subunit that can interact with either nAChR beta-2 or nAChR beta-4 to form a functional receptor. Mutations in this gene cause nocturnal frontal lobe epilepsy type 1. Polymorphisms in this gene that provide protection against nicotine addiction have been described. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 20-63346437-G-A is Benign according to our data. Variant chr20-63346437-G-A is described in ClinVar as [Benign]. Clinvar id is 1233246.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.000716 (109/152276) while in subpopulation NFE AF= 0.00128 (87/68010). AF 95% confidence interval is 0.00106. There are 0 homozygotes in gnomad4. There are 42 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High AC in GnomAd4 at 109 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CHRNA4 | NM_000744.7 | c.*301C>T | 3_prime_UTR_variant | 6/6 | ENST00000370263.9 | NP_000735.1 | ||
CHRNA4 | NM_001256573.2 | c.*301C>T | 3_prime_UTR_variant | 6/6 | NP_001243502.1 | |||
CHRNA4 | NR_046317.2 | n.2394C>T | non_coding_transcript_exon_variant | 6/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CHRNA4 | ENST00000370263.9 | c.*301C>T | 3_prime_UTR_variant | 6/6 | 1 | NM_000744.7 | ENSP00000359285 | P1 | ||
CHRNA4 | ENST00000463705.5 | n.2833C>T | non_coding_transcript_exon_variant | 5/5 | 1 | |||||
CHRNA4 | ENST00000631289.1 | n.499C>T | non_coding_transcript_exon_variant | 1/1 |
Frequencies
GnomAD3 genomes AF: 0.000723 AC: 110AN: 152156Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
110
AN:
152156
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000705 AC: 92AN: 130494Hom.: 0 AF XY: 0.000632 AC XY: 45AN XY: 71226
GnomAD3 exomes
AF:
AC:
92
AN:
130494
Hom.:
AF XY:
AC XY:
45
AN XY:
71226
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000923 AC: 391AN: 423416Hom.: 0 Cov.: 0 AF XY: 0.000906 AC XY: 211AN XY: 232860
GnomAD4 exome
AF:
AC:
391
AN:
423416
Hom.:
Cov.:
0
AF XY:
AC XY:
211
AN XY:
232860
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000716 AC: 109AN: 152276Hom.: 0 Cov.: 33 AF XY: 0.000564 AC XY: 42AN XY: 74434
GnomAD4 genome
AF:
AC:
109
AN:
152276
Hom.:
Cov.:
33
AF XY:
AC XY:
42
AN XY:
74434
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 14, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at